Literature DB >> 11697470

Comparison of the hanson microette and the Van Kel apparatus for in vitro release testing of topical semisolid formulations.

M Rapedius1, J Blanchard.   

Abstract

PURPOSE: The major goal of this study was to compare the relative utility of the Hanson Microette and the Van Kel apparatus, two fully automated devices, as in vitro release tests (IVRT) for semisolids. We attempted to develop methodology that can be used to discriminate formulation changes, and to evaluate the precision, reproducibility and technical complexity of each test apparatus.
METHODS: We chose the sunscreen Eusolex 232 (2-Phenylbenzimidazole-5-sulfonic acid) as a model compound, which was incorporated into an emulsion formulation prepared in our laboratory. Test conditions for the two IVRT were made as nearly identical as possible, in order to obtain an accurate comparison.
RESULTS: The formulations were tested and found to be physically stable throughout the entire study. Diffusion coefficients were apparatus-dependent but were independent of the drug concentration in the formulations. The IVRT data were plotted as amount released (microg/cm2) vs. square root of time (s(0.5)) and a linear relationship was obtained in each case. Both methods produced similar results and were able to detect changes in drug loading in the formulations.
CONCLUSIONS: The linear relationship between the amount released and the square root of time indicates a diffusion-controlled release of drug. Both apparatuses proved to be suitable as tests for formulation " sameness" according to the FDA's SUPAC-SS guidelines, during level 3 changes. However, each apparatus produced a different release profile for the drug. The choice of apparatus will depend upon a number of considerations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11697470     DOI: 10.1023/a:1012256923340

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  5 in total

Review 1.  Assessment of value and applications of in vitro testing of topical dermatological drug products.

Authors:  G L Flynn; V P Shah; S N Tenjarla; M Corbo; D DeMagistris; T G Feldman; T J Franz; D R Miran; D M Pearce; J A Sequeira; J Swarbrick; J C Wang; A Yacobi; J L Zatz
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

2.  Rate of release of medicaments from ointment bases containing drugs in suspension.

Authors:  T HIGUCHI
Journal:  J Pharm Sci       Date:  1961-10       Impact factor: 3.534

3.  In vitro release of hydrocortisone from topical preparations and automated procedure.

Authors:  V P Shah; J Elkins; J Hanus; C Noorizadeh; J P Skelly
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

4.  Dissolution kinetics of certain crystalline forms of prednisolone.

Authors:  D E Wurster; P W Taylor
Journal:  J Pharm Sci       Date:  1965-05       Impact factor: 3.534

5.  Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.

Authors:  P R Rege; V D Vilivalam; C C Collins
Journal:  J Pharm Biomed Anal       Date:  1998-09       Impact factor: 3.935

  5 in total
  1 in total

1.  In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells.

Authors:  Madhur Kulkarni; Shrikant Potdar; Abhijit A Date; Aditya Marfatiya
Journal:  Assay Drug Dev Technol       Date:  2020-10-09       Impact factor: 1.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.